Aquestive Therapeutics Inc (AQST)
4.07
+0.14
(+3.56%)
USD |
NASDAQ |
Apr 26, 16:00
3.97
-0.10
(-2.46%)
After-Hours: 20:00
Aquestive Therapeutics Revenue (TTM): 50.58M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.58M |
| September 30, 2023 | 48.06M |
| June 30, 2023 | 46.52M |
| March 31, 2023 | 46.54M |
| December 31, 2022 | 47.68M |
| September 30, 2022 | 48.08M |
| June 30, 2022 | 49.90M |
| March 31, 2022 | 51.98M |
| December 31, 2021 | 50.83M |
| September 30, 2021 | 46.90M |
| June 30, 2021 | 41.88M |
| March 31, 2021 | 48.21M |
| December 31, 2020 | 45.85M |
| Date | Value |
|---|---|
| September 30, 2020 | 55.12M |
| June 30, 2020 | 59.28M |
| March 31, 2020 | 48.73M |
| December 31, 2019 | 52.61M |
| September 30, 2019 | 53.01M |
| June 30, 2019 | 53.86M |
| March 31, 2019 | 56.66M |
| December 31, 2018 | 67.43M |
| September 30, 2018 | 62.80M |
| June 30, 2018 | 76.68M |
| March 31, 2018 | 73.89M |
| December 31, 2017 | 66.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
41.88M
Minimum
Jun 2021
59.28M
Maximum
Jun 2020
49.77M
Average
48.73M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Lifecore Biomedical Inc | 141.30M |
| Harrow Inc | 130.19M |
| Akebia Therapeutics Inc | 194.74M |
| 89bio Inc | -- |
| Geron Corp | 0.237M |